Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Confusional state? 230 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 230 reports of Confusional state have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.6% of all adverse event reports for EMPAGLIFLOZIN.

230
Reports of Confusional state with EMPAGLIFLOZIN
0.6%
of all EMPAGLIFLOZIN reports
5
Deaths
119
Hospitalizations

How Dangerous Is Confusional state From EMPAGLIFLOZIN?

Of the 230 reports, 5 (2.2%) resulted in death, 119 (51.7%) required hospitalization, and 33 (14.3%) were considered life-threatening.

Is Confusional state Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 230 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Confusional state?

METHOTREXATE (4,962) ACETAMINOPHEN (4,630) OXYCODONE (4,599) PREDNISONE (4,441) ADALIMUMAB (4,399) RITUXIMAB (4,020) TOCILIZUMAB (3,949) ABATACEPT (3,879) LEFLUNOMIDE (3,795) PIMAVANSERIN (3,779)

Which EMPAGLIFLOZIN Alternatives Have Lower Confusional state Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Confusional state Reports All Drugs Causing Confusional state EMPAGLIFLOZIN Demographics